Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drugs five years later. Bromocriptine.

M L Vance, W S Evans, M O Thorner

    Annals of Internal Medicine
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Bromocriptine effectively treats hyperprolactinemic conditions by suppressing prolactin and shrinking pituitary tumors. It also improves acromegaly and Parkinson's disease symptoms, but benefits reverse upon withdrawal.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ghrelin.

    Molecular metabolism·2015
    Same author

    Guidelines for acromegaly management: an update.

    The Journal of clinical endocrinology and metabolism·2009
    Same author

    The discovery of growth hormone-releasing hormone.

    Journal of neuroendocrinology·2008
    Same author

    Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.

    The Journal of clinical endocrinology and metabolism·2008
    Same author

    Modified alternate-day fasting regimens reduce cell proliferation rates to a similar extent as daily calorie restriction in mice.

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2008
    Same author

    The reliability and validity of the impact on lifestyle questionnaire in patients with acromegaly.

    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2006
    Same journal

    Correction to I.M. Matters News: Sleep medicine for seniors.

    Annals of internal medicine·2026
    Same journal

    Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

    Annals of internal medicine·2026
    Same journal

    Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

    Annals of internal medicine·2026
    Same journal

    Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

    Annals of internal medicine·2026
    Same journal

    Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

    Annals of internal medicine·2026
    Same journal

    Grappling with GLP-1 prescribing.

    Annals of internal medicine·2026
    See all related articles

    Area of Science:

    • Endocrinology
    • Neuropharmacology

    Background:

    • Bromocriptine is a dopamine receptor agonist.
    • It is used for hyperprolactinemic conditions, acromegaly, and Parkinson's disease.

    Purpose of the Study:

    • To summarize the therapeutic applications and effects of bromocriptine.

    Main Methods:

    • Review of clinical applications and patient outcomes with bromocriptine therapy.

    Main Results:

    • Bromocriptine effectively suppresses prolactin secretion, restores gonadal function, and reduces pituitary tumor size.
    • It improves clinical symptoms in acromegaly and enhances levodopa/carbidopa therapy in Parkinson's disease.
    • Therapeutic benefits are reversed upon drug withdrawal.

    Related Experiment Videos

    Conclusions:

    • Bromocriptine is a valuable treatment for specific endocrine and neurological disorders.
    • Its efficacy in managing hyperprolactinemia, acromegaly, and Parkinson's disease is well-established.
    • Treatment discontinuation leads to the recurrence of symptoms.